Burst CME™: Incorporating Multiparametric MRI to Guide Prostate Cancer Diagnosis

Release Date: September 30, 2025

Expiration Date: September 30, 2027

Activity Overview

The Burst CME™ format is an online, on-demand program designed to deliver concise modular education. In this third module, Stacy Loeb, MD, MSc, PhD (Hon), discusses the role of multiparametric MRI in prostate cancer risk assessment and ways to apply results to clinical decision-making.

Target Audience

This educational activity is primarily directed toward urologists. Other clinicians who diagnose prostate cancer are welcome to participate as well.

Learning Objectives

Upon successful completion of this activity, you should be better prepared to:

• Integrate biomarker testing and magnetic resonance imaging to improve risk stratification and early detection in patients with a high risk of prostate cancer

Faculty, Staff, and Planners’ Disclosures

The staff of Physicians’ Education Resource^®, LLC have no relevant financial relationships with ineligible companies.

PER^® mitigated all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.

Off-Label Disclosure and Disclaimer

This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a health care professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER^® or any company that provided commercial support for this activity.